MAR-CANDESARTAN / HCTZ 12.5 MG
HYDROCHLOROTHIAZIDE : 12.5 MG CANDESARTAN CILEXETIL : 32 MG · DIN 02432323 · MARCAN PHARMACEUTICALS INC
Health Canada status: APPROVED
What is MAR-CANDESARTAN / HCTZ?
MAR-CANDESARTAN / HCTZ 12.5 MG contains HYDROCHLOROTHIAZIDE : 12.5 MG CANDESARTAN CILEXETIL : 32 MG. It is listed in the Health Canada Drug Product Database under DIN 02432323, held by MARCAN PHARMACEUTICALS INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 24-Feb-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02432323 |
|---|---|
| Brand name | MAR-CANDESARTAN / HCTZ |
| Generic / active ingredient | HYDROCHLOROTHIAZIDE : 12.5 MG CANDESARTAN CILEXETIL : 32 MG |
| Manufacturer | MARCAN PHARMACEUTICALS INC |
| Strength | 12.5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09DA06 CANDERSARTAN AND DIURETICS |
| AHFS class | 40:28.20 ; 24:32.08 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 24-Feb-2017 |
What can be used instead?
Other Canadian products sharing ATC code C09DA06 CANDERSARTAN AND DIURETICS. 22 of 49 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ATACAND PLUS | 12.5 MG | TABLET | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02244021 |
| ATACAND PLUS | 12.5 MG | TABLET | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02332922 |
| ATACAND PLUS | 25 MG | TABLET | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02332957 |
| AURO-CANDESARTAN HCT | 12.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02421046 |
| AURO-CANDESARTAN HCT | 12.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02421038 |
| AURO-CANDESARTAN HCT | 25 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02421054 |
| CANDESARTAN HCT | 16 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02394812 |
| CANDESARTAN-HCTZ | 16.0 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02392275 |
| CANDESARTAN/HCTZ | 16 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02394804 |
| CANDESARTAN/HCTZ | 32 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02536064 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.